MANUFACTURING DEVELOPMENT AND SCALE-UP AGREEMENTManufacturing Development and Scale-Up Agreement • June 28th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This Manufacturing Development and Scale-up Agreement (the “Agreement”) is made as of March 19, 2012 (the “Effective Date”), between Liquidia Technologies, Inc., a Delaware corporation (“Liquidia”) having its principal place of business at Suite 100, 419 Davis Drive, Morrisville, NC 27560 and Chasm Technologies, Inc., a Massachusetts corporation (“Chasm”) with principal offices located at 85 Wagon Rd, Westwood, MA 02090.
ContractManufacturing Development and Scale-Up Agreement • June 28th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
MANUFACTURING DEVELOPMENT AND SCALE-UP AGREEMENTManufacturing Development and Scale-Up Agreement • February 26th, 2019 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This Manufacturing Development and Scale-up Agreement (the “Agreement”) is made as of March 19, 2012 (the “Effective Date”), between Liquidia Technologies, Inc., a Delaware corporation (“Liquidia”) having its principal place of business at Suite 100, 419 Davis Drive, Morrisville, NC 27560 and Chasm Technologies, Inc., a Massachusetts corporation (“Chasm”) with principal offices located at 85 Wagon Rd, Westwood, MA 02090.
ContractManufacturing Development and Scale-Up Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
